0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Melanoma Molecular Diagnostics Market Research Report 2022
Published Date: August 2022
|
Report Code: QYRE-Auto-9E6033
Home | Market Reports | Health| Health Conditions| Skin Conditions
Global Melanoma Molecular Diagnostics Market Size Status and Forecast 2021 2027

Global Melanoma Molecular Diagnostics Market Research Report 2022

Code: QYRE-Auto-9E6033
Report
August 2022
91 Pages
QYResearch
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Market Analysis and Insights: Global Melanoma Molecular Diagnostics Market
A molecular approach for diagnosing melanoma

The global Melanoma Molecular Diagnostics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, PCR accounting for % of the Melanoma Molecular Diagnostics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028.

While Clinical Diagnosis segment is altered to an % CAGR throughout this forecast period.
China Melanoma Molecular Diagnostics market size is valued at US$ million in 2021, while the North America and Europe Melanoma Molecular Diagnostics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Melanoma Molecular Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Melanoma Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Melanoma Molecular Diagnostics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Melanoma Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Melanoma Molecular Diagnostics market.
Global Melanoma Molecular Diagnostics Scope and Market Size
Melanoma Molecular Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Melanoma Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

PCR
FISH
DNA Sequencing
Gene Chip

Segment by Application

Clinical Diagnosis
Drug Screening
Research

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

Foundationmendicine
Novartis
Mole
Berryoncology
Gene+
Annoroad
Topgen
Geneis
Unitedgene
Inmedi
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Melanoma Molecular Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Melanoma Molecular Diagnostics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Melanoma Molecular Diagnostics Market Perspective (2017-2028)
2.2 Melanoma Molecular Diagnostics Growth Trends by Region
2.2.1 Melanoma Molecular Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Melanoma Molecular Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Melanoma Molecular Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Melanoma Molecular Diagnostics Market Dynamics
2.3.1 Melanoma Molecular Diagnostics Industry Trends
2.3.2 Melanoma Molecular Diagnostics Market Drivers
2.3.3 Melanoma Molecular Diagnostics Market Challenges
2.3.4 Melanoma Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Melanoma Molecular Diagnostics Players by Revenue
3.1.1 Global Top Melanoma Molecular Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Melanoma Molecular Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Melanoma Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Melanoma Molecular Diagnostics Revenue
3.4 Global Melanoma Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Melanoma Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Melanoma Molecular Diagnostics Revenue in 2021
3.5 Melanoma Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Melanoma Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Melanoma Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Melanoma Molecular Diagnostics Breakdown Data by Type
4.1 Global Melanoma Molecular Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Melanoma Molecular Diagnostics Forecasted Market Size by Type (2023-2028)
5 Melanoma Molecular Diagnostics Breakdown Data by Application
5.1 Global Melanoma Molecular Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Melanoma Molecular Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Melanoma Molecular Diagnostics Market Size (2017-2028)
6.2 North America Melanoma Molecular Diagnostics Market Size by Country (2017-2022)
6.3 North America Melanoma Molecular Diagnostics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Melanoma Molecular Diagnostics Market Size (2017-2028)
7.2 Europe Melanoma Molecular Diagnostics Market Size by Country (2017-2022)
7.3 Europe Melanoma Molecular Diagnostics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Melanoma Molecular Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Melanoma Molecular Diagnostics Market Size by Country (2017-2022)
8.3 Asia-Pacific Melanoma Molecular Diagnostics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Melanoma Molecular Diagnostics Market Size (2017-2028)
9.2 Latin America Melanoma Molecular Diagnostics Market Size by Country (2017-2022)
9.3 Latin America Melanoma Molecular Diagnostics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Melanoma Molecular Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Melanoma Molecular Diagnostics Market Size by Country (2017-2022)
10.3 Middle East & Africa Melanoma Molecular Diagnostics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Foundationmendicine
11.1.1 Foundationmendicine Company Detail
11.1.2 Foundationmendicine Business Overview
11.1.3 Foundationmendicine Melanoma Molecular Diagnostics Introduction
11.1.4 Foundationmendicine Revenue in Melanoma Molecular Diagnostics Business (2017-2022)
11.1.5 Foundationmendicine Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Melanoma Molecular Diagnostics Introduction
11.2.4 Novartis Revenue in Melanoma Molecular Diagnostics Business (2017-2022)
11.2.5 Novartis Recent Development
11.3 Mole
11.3.1 Mole Company Detail
11.3.2 Mole Business Overview
11.3.3 Mole Melanoma Molecular Diagnostics Introduction
11.3.4 Mole Revenue in Melanoma Molecular Diagnostics Business (2017-2022)
11.3.5 Mole Recent Development
11.4 Berryoncology
11.4.1 Berryoncology Company Detail
11.4.2 Berryoncology Business Overview
11.4.3 Berryoncology Melanoma Molecular Diagnostics Introduction
11.4.4 Berryoncology Revenue in Melanoma Molecular Diagnostics Business (2017-2022)
11.4.5 Berryoncology Recent Development
11.5 Gene+
11.5.1 Gene+ Company Detail
11.5.2 Gene+ Business Overview
11.5.3 Gene+ Melanoma Molecular Diagnostics Introduction
11.5.4 Gene+ Revenue in Melanoma Molecular Diagnostics Business (2017-2022)
11.5.5 Gene+ Recent Development
11.6 Annoroad
11.6.1 Annoroad Company Detail
11.6.2 Annoroad Business Overview
11.6.3 Annoroad Melanoma Molecular Diagnostics Introduction
11.6.4 Annoroad Revenue in Melanoma Molecular Diagnostics Business (2017-2022)
11.6.5 Annoroad Recent Development
11.7 Topgen
11.7.1 Topgen Company Detail
11.7.2 Topgen Business Overview
11.7.3 Topgen Melanoma Molecular Diagnostics Introduction
11.7.4 Topgen Revenue in Melanoma Molecular Diagnostics Business (2017-2022)
11.7.5 Topgen Recent Development
11.8 Geneis
11.8.1 Geneis Company Detail
11.8.2 Geneis Business Overview
11.8.3 Geneis Melanoma Molecular Diagnostics Introduction
11.8.4 Geneis Revenue in Melanoma Molecular Diagnostics Business (2017-2022)
11.8.5 Geneis Recent Development
11.9 Unitedgene
11.9.1 Unitedgene Company Detail
11.9.2 Unitedgene Business Overview
11.9.3 Unitedgene Melanoma Molecular Diagnostics Introduction
11.9.4 Unitedgene Revenue in Melanoma Molecular Diagnostics Business (2017-2022)
11.9.5 Unitedgene Recent Development
11.10 Inmedi
11.10.1 Inmedi Company Detail
11.10.2 Inmedi Business Overview
11.10.3 Inmedi Melanoma Molecular Diagnostics Introduction
11.10.4 Inmedi Revenue in Melanoma Molecular Diagnostics Business (2017-2022)
11.10.5 Inmedi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Melanoma Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of PCR
    Table 3. Key Players of FISH
    Table 4. Key Players of DNA Sequencing
    Table 5. Key Players of Gene Chip
    Table 6. Global Melanoma Molecular Diagnostics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Melanoma Molecular Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Melanoma Molecular Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Melanoma Molecular Diagnostics Market Share by Region (2017-2022)
    Table 10. Global Melanoma Molecular Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Melanoma Molecular Diagnostics Market Share by Region (2023-2028)
    Table 12. Melanoma Molecular Diagnostics Market Trends
    Table 13. Melanoma Molecular Diagnostics Market Drivers
    Table 14. Melanoma Molecular Diagnostics Market Challenges
    Table 15. Melanoma Molecular Diagnostics Market Restraints
    Table 16. Global Melanoma Molecular Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Melanoma Molecular Diagnostics Market Share by Players (2017-2022)
    Table 18. Global Top Melanoma Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Molecular Diagnostics as of 2021)
    Table 19. Ranking of Global Top Melanoma Molecular Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Melanoma Molecular Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Melanoma Molecular Diagnostics Product Solution and Service
    Table 23. Date of Enter into Melanoma Molecular Diagnostics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Melanoma Molecular Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Melanoma Molecular Diagnostics Revenue Market Share by Type (2017-2022)
    Table 27. Global Melanoma Molecular Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Melanoma Molecular Diagnostics Revenue Market Share by Type (2023-2028)
    Table 29. Global Melanoma Molecular Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Melanoma Molecular Diagnostics Revenue Market Share by Application (2017-2022)
    Table 31. Global Melanoma Molecular Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Melanoma Molecular Diagnostics Revenue Market Share by Application (2023-2028)
    Table 33. North America Melanoma Molecular Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Melanoma Molecular Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Melanoma Molecular Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Melanoma Molecular Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Melanoma Molecular Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Melanoma Molecular Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Melanoma Molecular Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Melanoma Molecular Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Melanoma Molecular Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Melanoma Molecular Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Foundationmendicine Company Detail
    Table 44. Foundationmendicine Business Overview
    Table 45. Foundationmendicine Melanoma Molecular Diagnostics Product
    Table 46. Foundationmendicine Revenue in Melanoma Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 47. Foundationmendicine Recent Development
    Table 48. Novartis Company Detail
    Table 49. Novartis Business Overview
    Table 50. Novartis Melanoma Molecular Diagnostics Product
    Table 51. Novartis Revenue in Melanoma Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 52. Novartis Recent Development
    Table 53. Mole Company Detail
    Table 54. Mole Business Overview
    Table 55. Mole Melanoma Molecular Diagnostics Product
    Table 56. Mole Revenue in Melanoma Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 57. Mole Recent Development
    Table 58. Berryoncology Company Detail
    Table 59. Berryoncology Business Overview
    Table 60. Berryoncology Melanoma Molecular Diagnostics Product
    Table 61. Berryoncology Revenue in Melanoma Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 62. Berryoncology Recent Development
    Table 63. Gene+ Company Detail
    Table 64. Gene+ Business Overview
    Table 65. Gene+ Melanoma Molecular Diagnostics Product
    Table 66. Gene+ Revenue in Melanoma Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 67. Gene+ Recent Development
    Table 68. Annoroad Company Detail
    Table 69. Annoroad Business Overview
    Table 70. Annoroad Melanoma Molecular Diagnostics Product
    Table 71. Annoroad Revenue in Melanoma Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 72. Annoroad Recent Development
    Table 73. Topgen Company Detail
    Table 74. Topgen Business Overview
    Table 75. Topgen Melanoma Molecular Diagnostics Product
    Table 76. Topgen Revenue in Melanoma Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 77. Topgen Recent Development
    Table 78. Geneis Company Detail
    Table 79. Geneis Business Overview
    Table 80. Geneis Melanoma Molecular Diagnostics Product
    Table 81. Geneis Revenue in Melanoma Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 82. Geneis Recent Development
    Table 83. Unitedgene Company Detail
    Table 84. Unitedgene Business Overview
    Table 85. Unitedgene Melanoma Molecular Diagnostics Product
    Table 86. Unitedgene Revenue in Melanoma Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 87. Unitedgene Recent Development
    Table 88. Inmedi Company Detail
    Table 89. Inmedi Business Overview
    Table 90. Inmedi Melanoma Molecular Diagnostics Product
    Table 91. Inmedi Revenue in Melanoma Molecular Diagnostics Business (2017-2022) & (US$ Million)
    Table 92. Inmedi Recent Development
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Melanoma Molecular Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. PCR Features
    Figure 3. FISH Features
    Figure 4. DNA Sequencing Features
    Figure 5. Gene Chip Features
    Figure 6. Global Melanoma Molecular Diagnostics Market Share by Application in 2021 & 2028
    Figure 7. Clinical Diagnosis Case Studies
    Figure 8. Drug Screening Case Studies
    Figure 9. Research Case Studies
    Figure 10. Melanoma Molecular Diagnostics Report Years Considered
    Figure 11. Global Melanoma Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Melanoma Molecular Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Melanoma Molecular Diagnostics Market Share by Region: 2021 VS 2028
    Figure 14. Global Melanoma Molecular Diagnostics Market Share by Players in 2021
    Figure 15. Global Top Melanoma Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Molecular Diagnostics as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Melanoma Molecular Diagnostics Revenue in 2021
    Figure 17. North America Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Melanoma Molecular Diagnostics Market Share by Country (2017-2028)
    Figure 19. United States Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Melanoma Molecular Diagnostics Market Share by Country (2017-2028)
    Figure 23. Germany Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Melanoma Molecular Diagnostics Market Share by Region (2017-2028)
    Figure 31. China Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Melanoma Molecular Diagnostics Market Share by Country (2017-2028)
    Figure 39. Mexico Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Melanoma Molecular Diagnostics Market Share by Country (2017-2028)
    Figure 43. Turkey Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Melanoma Molecular Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Foundationmendicine Revenue Growth Rate in Melanoma Molecular Diagnostics Business (2017-2022)
    Figure 46. Novartis Revenue Growth Rate in Melanoma Molecular Diagnostics Business (2017-2022)
    Figure 47. Mole Revenue Growth Rate in Melanoma Molecular Diagnostics Business (2017-2022)
    Figure 48. Berryoncology Revenue Growth Rate in Melanoma Molecular Diagnostics Business (2017-2022)
    Figure 49. Gene+ Revenue Growth Rate in Melanoma Molecular Diagnostics Business (2017-2022)
    Figure 50. Annoroad Revenue Growth Rate in Melanoma Molecular Diagnostics Business (2017-2022)
    Figure 51. Topgen Revenue Growth Rate in Melanoma Molecular Diagnostics Business (2017-2022)
    Figure 52. Geneis Revenue Growth Rate in Melanoma Molecular Diagnostics Business (2017-2022)
    Figure 53. Unitedgene Revenue Growth Rate in Melanoma Molecular Diagnostics Business (2017-2022)
    Figure 54. Inmedi Revenue Growth Rate in Melanoma Molecular Diagnostics Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$2900
This license allows only one user to access the PDF.

Electronic (PDF)
$4350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$5800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Novocure
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Sclerotherapy Market Insights and Forecast to 2027
Global Sclerotherapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-11F4407
Thu Sep 15 00:00:00 UTC 2022

Add to Cart

Global Pruritus Therapeutics Market Size Status and Forecast 2021 2027
Global Pruritus Therapeutics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-17C2560
Tue Sep 13 00:00:00 UTC 2022

Add to Cart

Global Triamcinolone Acetonide Nasal Industry Research Report Growth Trends and Competitive Analysis 2022 2028
Global Triamcinolone Acetonide Nasal Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-2X12323
Wed Sep 07 00:00:00 UTC 2022

Add to Cart

Global Tacrolimus Ointment Industry Research Report Growth Trends and Competitive Analysis 2022 2028
Global Tacrolimus Ointment Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-13E12088
Wed Sep 07 00:00:00 UTC 2022

Add to Cart